AIM: The aim of the study was to evaluate the yields of 2-deoxy-2-[18F]-fluoro-D-glucose positron-emission tomography/magnetic resonance imaging (18F-FDG-PET/MRI) and 18F-FDG-PET/computed tomography (CT) for the detection of metastatic involvement of locoregional neck nodes in patients with head and neck malignancy. PATIENTS AND METHODS: A total of 90 patients (66 men and 24 women) met the inclusion criteria. Preoperative staging was performed: 53 examinations using PET/CT and 37 using PET/MRI. RESULTS: For PET/MRI, the study demonstrated a sensitivity of 89%, specificity of 64%, positive predictive value of 85%, and negative predictive value of 70%; PET/CT had a sensitivity of 95%, specificity 47%, positive predictive value of 82%, and negative predictive value of 78%. CONCLUSION: Both methods have a high yield in N-clinical staging with statistically insignificant differences. We assume PET/MRI to be the first-choice method in organ-targeted examinations, for pediatric patients and repeat examinations. In cases of MRI contraindication, PET/CT can be used with no impact on the quality of care.

Department of Immunochemistry Diagnostics University Hospital in Pilsen Faculty of Medicine in Pilsen Charles University Pilsen Czech Republic

Department of Medical Imaging University Hospital in Pilsen Faculty of Medicine in Pilsen Charles University Pilsen Czech Republic

Department of Otorhinolaryngology University Hospital in Pilsen Faculty of Medicine in Pilsen Charles University Pilsen Czech Republic

Department of Pathology University Hospital in Pilsen Faculty of Medicine in Pilsen Charles University Pilsen Czech Republic

Zobrazit více v PubMed

Evers C, Ostheimer C, Sieker F, Vordermark D, Medenwald D. Benefit from surgery with additional radiotherapy in N1 head and neck cancer at the time of IMRT: A population-based study on recent developments. PLoS One. 2020;15(2):e0229266. doi: 10.1371/journal.pone.0229266. PubMed DOI PMC

Curado MP, Hashibe M. Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol. 2009;21(3):194–200. doi: 10.1097/CCO.0b013e32832a68ca. PubMed DOI

Jones T, Townsend D. History and future technical innovation in positron-emission tomography. J Med Imaging. 2017;4(1):011013. doi: 10.1117/1.JMI.4.1.011013. PubMed DOI PMC

Paulino AC, Koshy M, Howell R, Schuster D, Davis LW. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2005;61(5):1385–1392. PubMed

Brierley JD, Gospodarowicz MK, Wittekind Ch. TNM Classification of Malignant Tumours. New Jersey, Wiley Blackwell, 2016;Eighth Edition:17–51.

Baulch J, Gandhi M, Sommerville J, Panizza B. 3T MRI evaluation of large nerve perineural spread of head and neck cancers. J Med Imaging Radiat Oncol. 2015;59(5):578–585. doi: 10.1111/1754-9485.12338. PubMed DOI

Chawla SC, Federman N, Zhang D, Nagata K, Nuthakki S, McNitt-Gray M, Boechat MI. Estimated cumulative radiation dose from PET/CT in children with malignancies: A 5-year retrospective review. Pediatr Radiol. 2010;40(5):681–686. doi: 10.1007/s00247-009-1434-z. PubMed DOI PMC

Sumi M, Kimura Y, Sumi T, Nakamura T. Diagnostic performance of MRI relative to CT for metastatic nodes of head and neck squamous cell carcinomas. J Magn Reson Imaging. 2007;26(6):1626–1633. PubMed

Ng SH, Yen TC, Chang JT, Chan SC, Ko SF, Wang HM, Lee LY, Kang CJ, Wong AM, Liao CT. Prospective study of [18F] fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol. 2006;24(27):4371–4376. PubMed

Kubiessa K, Purz S, Gawlitza M, Kühn A, Fuchs J, Steinhoff KG, Boehm A, Sabri O, Kluge R, Kahn T, Stumpp P. Initial clinical results of simultaneous 18F-FDG PET/MRI in comparison to 18F-FDG PET/CT in patients with head and neck cancer. Eur J Nucl Med Mol Imaging. 2014;41(4):639–648. doi: 10.1007/s00259-013-2633-2. PubMed DOI

Beyer T, Freudenberg LS, Czernin J, Townsend DW. The future of hybrid imaging-part 3: PET/MR, small-animal imaging and beyond. Insights Imaging. 2011;2(3):235–246. PubMed PMC

Antoch G, Bockisch A. Combined PET/MRI: A new dimension in whole-body oncology imaging. Eur J Nucl Med Mol Imaging. 2009;36(1):113–120. doi: 10.1007/s00259-008-0951-6. PubMed DOI

Castelijns JA. PET-MRI in the head and neck area: challenges and new directions. Eur Radiol. 2011;21(11):2425–2426. doi: 10.1007/s00330-011-2181-8. PubMed DOI PMC

Huang SH, Chien CY, Lin WC, Fang FM, Wang PW, Lui CC, Huang YC, Hung BT, Tu MC, Chang CC. A comparative study of fused FDG PET/MRI, PET/CT, MRI, and CT imaging for assessing surrounding tissue invasion of advanced buccal squamous cell carcinoma. Clin Nucl Med. 2011;36(7):518–525. doi: 10.1097/RLU.0b013e318217566f. PubMed DOI

Partovi S, Kohan A, Vercher-Conejero JL, Rubbert C, Margevicius S, Schluchter MD, Gaeta C, Faulhaber P, Robbin MR. Qualitative and quantitative performance of 18F-FDG-PET/MRI versus 18F-FDG-PET/CT in patients with head and neck cancer. Am J Neuroradiol. 2014;35(10):1970–1975. doi: 10.3174/ajnr.A3993. PubMed DOI PMC

Varoquaux A, Rager O, Poncet A, Delattre BM, Ratib O, Becker CD, Dulguerov P, Dulguerov N, Zaidi H, Becker M. Detection and quantification of focal uptake in head and neck tumours: (18)F-FDG PET/MR versus PET/CT. Eur J Nucl Med Mol Imaging. 2014;41(3):462–475. doi: 10.1007/s00259-013-2580-y. PubMed DOI PMC

Szyszko TA, Cook GJR. PET/CT and PET/MRI in head and neck malignancy. Clin Radiol. 2018;73(1):60–69. doi: 10.1016/j.crad.2017.09.001. PubMed DOI

Grosse J, Hellwig D. PET/CT and PET/MRI in head and neck cancer. Laryngorhinootologie. 2020;99(1):12–21. doi: 10.1055/a-1057-1244. PubMed DOI

Samolyk-Kogaczewska N, Sierko E, Dziemianczyk-Pakiela D, Nowaszewska KB, Lukasik M, Reszec J. Usefulness of hybrid PET/MRI in clinical evaluation of head and neck cancer patients. Cancers. 2020;12(2):E511. doi: 10.3390/cancers12020511. PubMed DOI PMC